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Introduction
The precise regulation of actin filament assembly is critical for 
cytoskeletal architecture in many cellular processes, including 
migration, shape maintenance, and contractile function. A strik-
ing example of strictly orchestrated actin filament assembly is 
found in skeletal muscle cells, where semicrystalline arrays of 
actin (thin) and myosin (thick) filaments comprise the contrac-
tile apparatus (Clark et al., 2002). In sarcomeres, thin filament 
fast-growing (barbed) ends are anchored in the Z-line, and their 
slow-growing (pointed) ends extend into the middle of the sar-
comere, terminating at the H-zone. Thin filaments are extremely 
uniform in length but dynamic at their ends, where new actin 
monomer can be incorporated by subunit exchange (Littlefield 
et al., 2001). Thin filament pointed ends are capped by tropo-
modulins (Tmods), which interact with tropomyosins (TMs) 
and cap TM-decorated actin ends more tightly than bare actin 
ends (Weber et al., 1994, 1999; Kostyukova et al., 2005, 2006). 
Tmod-mediated pointed-end dynamics are a key regulator of thin 
filament length in mammalian cardiac muscle and invertebrate 
striated muscles (for review see Littlefield and Fowler, 2008), 
but Tmod’s roles in thin filament length regulation in skeletal mus-
cle and how thin filament length regulation influences in vivo 
skeletal muscle physiology remain unknown.
Tmods may regulate thin filament length in skeletal mus-
cle through several mechanisms. Mammalian skeletal muscle 
contains nebulin, a giant rodlike protein that coextends with 
actin along thin filaments (McElhinny et al., 2003). Nebulin has 
been proposed to be a molecular ruler that determines the posi-
tion of Tmod relative to the Z-line, thereby specifying thin fila-
ment length (Kruger et al., 1991; Labeit et al., 1991; McElhinny 
et al., 2001; for review see Littlefield and Fowler, 2008). However, 
recent evidence challenges this model because nebulin does   
not coextend with actin along the entire thin filament (Castillo   
et al., 2009). Rather, a nebulin-free actin pointed-end extension   
demarcates the periphery of the H-zone (Castillo et al., 2009). 
The lengths of the actin filament extensions past the N terminus 
of nebulin vary across skeletal muscles, determining muscle-
specific thin filament lengths and sarcomere length–tension   
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skeletal muscles. However, Tmod isoforms do not substitute for 
one another functionally, revealing novel functions of Tmods as 
regulators of skeletal muscle physiology.
Results
Tmod1 is dispensable for skeletal muscle 
development, myofibrillogenesis, and thin 
filament length specification
We previously rescued the early embryonic lethality of the 
Tmod1-null  mouse  with  a  cardiac-specific  transgene  that 
places Tmod1 under the control of the  myosin heavy chain 
(-MHC)  promoter  (Tmod1
/Tg(-MHC–Tmod1);  hereafter  re-
ferred  to  as  Tmod1
/Tg+;  McKeown  et  al.,  2008).  This   
enabled us to study the requirement of Tmod1 in skeletal myo-
fibril assembly during development, which occurs starting 
around E13 of mouse embryogenesis (Miller, 1991). As ex-
pected from the absence of Tmod1 expression in the noncar-
diac tissues of Tmod1
/Tg+ mice (McKeown et al., 2008; Nowak 
et al., 2009), Western blotting of E15.5 embryonic leg and flank 
skeletal muscle lysates demonstrated the absence of Tmod1 
from Tmod1
/Tg+ embryos (Fig. 1 A). Tmod1 staining was 
relationships (Granzier et al., 1991; Castillo et al., 2009). Further-
more, skeletal muscles from nebulin-null mice have shorter 
and somewhat more variable lengths instead of completely dys-
regulated lengths that would be expected if nebulin were a true 
ruler (Bang et al., 2006; Witt et al., 2006). Thus, it has been sug-
gested instead that nebulin stabilizes a large core region of the 
thin filament, whereas pointed-end actin dynamics (as regu-
lated by Tmods and interactions with TMs) fine-tune uniform   
filament lengths in skeletal muscle (for review see Littlefield 
and Fowler, 2008).
Four Tmod  isoforms  are  present  within  mammals  that 
could allow them to fine-tune thin filament lengths at the pointed 
end. Tmod1 is expressed predominantly in terminally differen-
tiated, postmitotic cells (such as erythrocytes, lens fiber cells, 
neurons, and striated muscle), Tmod2 is expressed exclusively 
in neuronal tissues, Tmod3 is expressed ubiquitously, and 
Tmod4 is restricted to skeletal muscle in mammals (Fowler, 
1987, 1990; Sung et al., 1992; Watakabe et al., 1996; Almenar-
Queralt et al., 1999b; Cox and Zoghbi, 2000; Conley et al., 
2001). With these expression patterns, Tmod1, -3, and -4 are all 
potential regulators of pointed-end actin dynamics and thin fila-
ment lengths in skeletal muscle sarcomeres. Based on studies in 
cardiac muscle, changes in overall levels of Tmods via relative 
isoform expression could affect the extent of pointed-end capping, 
thus regulating thin filament lengths (for review see Littlefield 
and Fowler, 2008). Furthermore, at least Tmod1 and -4 have 
differential binding to TMs (Greenfield and Fowler, 2002; 
Kostyukova et al., 2006, 2007). Therefore, we hypothesized that 
a combination of Tmod isoform expression and avidity for 
TMs regulates thin filament length in skeletal muscles.
To decipher the role of Tmods in regulating thin filament 
length in skeletal muscle, we used a genetic targeting approach 
to delete Tmod1 from skeletal muscle. As shown in previous 
studies using Tmod1-null mice, global deletion of Tmod1 results 
in failure of cardiac myofibril assembly, contraction, and looping 
morphogenesis, resulting in embryonic lethality at embryonic 
day (E) 9.5 (Chu et al., 2003; Fritz-Six et al., 2003). Because this 
occurs before the onset of skeletal myogenesis, it is impossible 
to use Tmod1-null mice to determine the role of Tmod1 in skel-
etal muscle. To surmount this obstacle, our laboratory rescued 
the lethality of Tmod1-null mice through the use of a cardiac- 
specific transgene, generating mice that express Tmod1 in the 
heart but lack Tmod1 in all other tissues, including skeletal mus-
cle (McKeown et al., 2008). In this study, we report that, in con-
trast to cardiac muscle, Tmod1 is dispensable for the correct 
specification  of  thin  filament  lengths  in  both  embryonic  and 
adult skeletal muscle because Tmod3 and/or -4 is recruited to the 
pointed ends when Tmod1 is absent. This compensatory regula-
tion of lengths occurs despite the fact that Tmod3 and -4 levels 
do not change when Tmod1 is absent, and Tmod3 and -4 both 
interact with striated muscle TMs more weakly than does 
Tmod1. Surprisingly, we discovered that deletion of Tmod1 de-
presses skeletal muscle contractile function in a thin filament 
length–independent manner and shifts fiber types toward a faster 
composition. This is the first study to provide an in vivo demon-
stration that particular Tmod isoforms can substitute for one an-
other to maintain correct muscle-specific thin filament lengths in 
Figure 1.  Tmod1 is dispensable for myofibril assembly. (A) Western blots 
of E15.5 mouse embryonic leg and flank muscle tissue lysates show ab-
sence of Tmod1 in Tmod1
/Tg+ muscles. Tubulin and actin were loading 
controls. Molecular mass is indicated in kilodaltons. (B–I) Skeletal muscle 
from Tmod1
+/+ and Tmod1
/Tg+ E15.5 mouse embryos stained for Tmod1, 
F-actin, and -actinin. Arrowheads denote H-zones. Bars, 3 µm.97 Tropomodulin isoform functions in skeletal muscle • Gokhin et al.
Tmod1-binding site and localizes near the H-zone boundary 
where the thin filament pointed ends reside (McElhinny et al., 
2001). Although  Tmod1
/Tg+  embryos  completely  lacked 
Tmod1 in their skeletal muscle, nebulin still assembled into sar-
comeres and coextended along thin filaments, as indicated by 
normal  M1M2M3  staining  (Fig.  2).  We  also  measured  no 
changes  in  the  localization  of  the  M1M2M3  domain  with   
respect to the distance from the Z-line, as determined by distrib-
uted  deconvolution  (Table  I).  Importantly,  the  thin  filament 
pointed ends continued to extend beyond the nebulin N termi-
nus, with the filament ends 1.2 µm from the Z-line and the 
M1M2M3 domain 0.85 µm from the Z-line (Table I), which   
is  qualitatively  similar  to  observations  in  rabbit  muscles 
also not detected in cryosections of the embryonic Tmod1
/Tg+ 
skeletal muscle, confirming that the -MHC promoter is car-
diac specific and not leaky (Fig. 1 and Fig. S1; Rindt et al., 
1995; Sussman et al., 1998b). Muscle development and myofi-
bril assembly appeared normal, based on normal myotube sizes, 
alignment, and morphology in cryosections of embryonic mus-
cles (Fig. S1).
To  examine  myofibrillogenesis  during  skeletal  muscle   
development in the absence of Tmod1, we performed immuno-
fluorescence staining for -actinin at the Z-lines and fluorescent 
phalloidin staining for F-actin on frozen sections of E15.5 
Tmod1
/Tg+  embryos.  Surprisingly,  skeletal  muscle  from 
Tmod1
/Tg+ embryos was striated and appeared to have regu-
lated thin filament lengths, as demonstrated by uniform gaps in 
F-actin at the H-zone and regular periodic striations of -actinin 
(Fig. 1). Thus, in stark contrast to cardiac muscle (Chu et al., 
2003; Fritz-Six et al., 2003), skeletal muscle myofibrillogenesis, 
including the assembly of thin filaments with regulated lengths, 
does not require Tmod1. Next, using phalloidin staining for   
F-actin to visualize thin filaments, we measured thin filament 
lengths by distributed deconvolution analysis (Littlefield and 
Fowler,  2002).  Surprisingly,  we  found  that  Tmod1
+/+  and 
Tmod1
/Tg+ embryonic muscles had statistically indistinguish-
able thin filament lengths of 1.2 µm (Table I), indicating that 
Tmod1 is not necessary to specify thin filament length in skeletal 
muscle  in  vivo. Thus,  we  conclude  that  developing  skeletal 
muscle possesses a Tmod1-independent mechanism to specify 
thin filament length that is not present in cardiac muscle.
The giant protein nebulin is a skeletal muscle–specific 
binding partner of Tmod1 and has been proposed to act together 
with Tmods to regulate skeletal muscle thin filament lengths 
(Kruger et al., 1991; Labeit et al., 1991; McElhinny et al., 2001). 
Although loss of Tmod1 did not affect myofibril assembly, 
we  reasoned that nebulin localization might be perturbed in 
Tmod1
/Tg+ embryonic muscle. To address this possibility, we 
stained embryonic skeletal muscle with antibodies generated 
against  the  N-terminal  M1M2M3  domain  of  nebulin  (Castillo   
et  al.,  2009). The  nebulin  M1M2M3  domain  contains  the 
Table I.  Thin filament length parameters determined by distributed deconvolution analysis of fluorescence images
Muscle type Phalloidin Nebulin M1M2M3 Tmod
Mean ± SD Min–max n Mean ± SD Min–max n Mean ± SD Min–max n
µm µm µm µm µm µm
Embryonic flank
Tmod1
+/+ 1.18 ± 0.09 1.02–1.35 122 0.86 ± 0.04 0.77–0.98 57 1.23 ± 0.10 1.09–1.50 27
Tmod1
/Tg+ 1.19 ± 0.06 1.07–1.36 100 0.85 ± 0.04 0.75–0.97 94 1.26 ± 0.07 1.13–1.40 43
Adult EDL
Tmod1
+/+ 1.06 ± 0.07 0.92–1.25 79 0.84 ± 0.07 0.68–1.06 50 1.11 ± 0.06 0.92–1.27 67
Tmod1
/Tg+ 1.07 ± 0.06 0.94–1.21 67 0.85 ± 0.04 0.75–1.00 61 1.13 ± 0.09 0.89–1.33 82
Adult soleus
Tmod1
+/+ 1.15 ± 0.07 0.95–1.29 86 0.90 ± 0.05 0.83–1.03 50 1.22 ± 0.08 1.02–1.34 42
Tmod1
/Tg+ 1.16 ± 0.07 1.00–1.31 114 0.89 ± 0.03 0.81–0.96 52 1.22 ± 0.06 1.11–1.37 51
Min, minimum; max, maximum. All lengths are in micrometers from the Z-line, measured from n myofibrils from three to four mice per genotype. All nebulin M1M2M3 
lengths were significantly closer to the Z-line than corresponding Tmod lengths (P < 10
38). For embryonic flank phalloidin, nebulin M1M2M3, and Tmod, P = 0.08, 
P = 0.64, and P = 0.14, respectively. For adult EDL phalloidin, nebulin M1M2M3, and Tmod, P = 0.36, P = 0.48, and P = 0.20, respectively. For adult soleus phal-
loidin, nebulin M1M2M3, and Tmod, P = 0.39, P = 0.16, and P = 0.87, respectively.
Figure  2.  Tmod1  is  dispensable  for  correct  localization  of  nebulin.  
(A–H)  Skeletal  muscle  from  Tmod1
+/+  (A–D)  and  Tmod1
/Tg+  (E–H) 
E15.5 mouse embryos was stained for nebulin M1M2M3, F-actin, and 
-actinin. Arrowheads denote nebulin M1M2M3 stripes flanking the 
H-zone. Bars, 3 µm.JCB • VOLUME 189 • NUMBER 1 • 2010   98
Tmod1 is dispensable for the structure of 
adult skeletal muscle
Tmod1 is not required for embryonic skeletal muscle develop-
ment (Fig. 1 and Fig. S1), but Tmod1 still could be important 
for the maintenance of adult muscle structure during contrac-
tion and use. Thus, we investigated the properties of skeletal 
muscle from musculoskeletally mature (1 mo old) Tmod1
+/+ 
and Tmod1
/Tg+ animals (Gokhin et al., 2008). Coomassie-
stained gels of skeletal muscle lysates showed no obvious dif-
ferences in the major protein composition of various muscles, 
including the tibialis anterior (TA), diaphragm, extensor digi-
torum longus (EDL), and soleus (Fig. S2), which reflect a va-
riety  of  fiber  type  compositions  and  muscle  architectures 
(Burkholder et al., 1994). Transmission EM (TEM) of the 
EDL did not reveal any obvious ultrastructural differences be-
tween Tmod1
+/+ and Tmod1
/Tg+ muscles, with Tmod1
/Tg+ 
muscles  exhibiting  intact  Z-  and  M-lines,  no  evidence  of 
split or degenerated myofibrils, and no signs of swollen or ag-
gregated mitochondria (Fig. 4 A). We next used immunofluo-
rescence  staining  to  visualize  various  constituents  of  adult 
myofibrils, including -actinin (a structural element of the 
Z-line), the C-terminal M160–164 repeat domain of nebulin 
(also in the Z-line), and myomesin (a structural element of the 
M-line). No differences in the sarcomeric localizations of 
any of these proteins could be found between Tmod1
+/+ and 
Tmod1
/Tg+ muscles (Fig. 4, B–D). Moreover, confocal fluo-
rescence microscopy and low magnification TEM of EDL and 
soleus muscles (Fig. 4 and not depicted) demonstrated that 
myofibrils were relatively well aligned in 1-mo-old animals of 
both genotypes. Although adjacent myofibrils were somewhat 
(Castillo et al., 2009). Thus, nebulin is properly localized 
even in the absence of Tmod1.
Tmod4 but not Tmod3 substitutes for 
Tmod1 in embryonic skeletal muscle
In the absence of Tmod1, embryonic skeletal muscle thin fila-
ments still have the correct length. We reasoned that Tmod3 and -4 
isoforms, which are also expressed in striated muscles, could 
be substituting for Tmod1 and capping thin filament pointed 
ends in Tmod1
/Tg+ skeletal muscle. Immunofluorescence 
staining of cryosectioned embryos shows that the distribution 
of Tmod3, the ubiquitous Tmod isoform, appeared to be diffuse 
and was not localized to pointed ends in either Tmod1
+/+ or 
Tmod1
/Tg+ embryonic skeletal muscle (Fig. 3, A–H). In con-
trast, Tmod4, the skeletal muscle–specific isoform, localized at 
thin filament pointed ends in embryonic skeletal muscle of both 
Tmod1
+/+ and Tmod1
/Tg+ mice (Fig. 3, I–P). Although staining 
for Tmod4 at the pointed ends in Tmod1
+/+ muscle could poten-
tially be caused by some antibody cross-reactivity with Tmod1, 
this cannot account for pointed-end staining in Tmod1
/Tg+ 
embryonic muscles in which Tmod1 is not present. Thus, Tmod4 
does indeed localize to pointed ends in the absence of Tmod1. 
Next, we performed distributed deconvolution measurements 
and found that length measurements based on Tmod localization 
corroborated those observed with phalloidin staining. Thin fila-
ment  pointed  ends,  as  measured  by  Tmod4  localization  in 
Tmod1
/Tg+ embryonic muscle and by both Tmod1 and -4 lo-
calization in Tmod1
+/+ muscle, were the same distance from the 
Z-line (Table I). Thus, Tmod4 but not Tmod3 substitutes for 
Tmod1 in Tmod1
/Tg+ embryonic muscle.
Figure 3.  Tmod4 but not Tmod3 substitutes for Tmod1 by capping thin filament pointed ends in embryonic muscle. (A–P) Skeletal muscle from Tmod1
+/+ 
(A–D and I–L) and Tmod1
/Tg+ (E–H and M–P) E15.5 mouse embryos stained for F-actin, -actinin, and either Tmod3 or -4. Tmod3 is diffusely localized, 
whereas Tmod4 localizes to the pointed ends in the presence or absence of Tmod1. Arrowheads denote H-zones. Bars, 5 µm.99 Tropomodulin isoform functions in skeletal muscle • Gokhin et al.
blotting for Tmod1 confirmed that Tmod1 was completely 
absent from Tmod1
/Tg+ adult EDL muscle (Fig. 5 A). How-
ever, both Tmod3 and -4 were present in Tmod1
/Tg+ EDL 
muscle at levels that are not qualitatively different from those 
observed in Tmod1
+/+ muscle (Fig. 5 A). These results were 
also observed in adult TA, diaphragm, and soleus muscles 
(Fig. S3). Immunofluorescence staining of EDL muscles re-
vealed that both Tmod3 and -4 have the potential to substitute 
for Tmod1 in capping thin filaments. As expected, Tmod1 lo-
calized to the pointed ends of the thin filaments in Tmod1
+/+ 
muscle but was undetectable in Tmod1
/Tg+ muscle (Fig. 5 B). 
In contrast, Tmod3 localized weakly to regions on either   
side of the Z-line as well as to the M-line in Tmod1
+/+ muscle, 
but  when  Tmod1  was  deleted,  Tmod3  redistributed  from 
these regions to the thin filament pointed ends (Fig. 5 C). In 
contrast, Tmod4 localized to the thin filament pointed ends 
regardless of the presence of Tmod1 (Fig. 5 D). Therefore, 
both Tmod3 and -4 can substitute for Tmod1 in adult skeletal 
muscle.  Analogous  immunofluorescence  staining  experi-
ments on the soleus confirmed that these observations are not 
EDL specific (Fig. S3). We performed distributed deconvolu-
tion analysis and found that length measurements based on 
Tmod  localization  corroborated  those  obtained  by  F-actin 
staining. Thus, in EDL and soleus muscles from Tmod1
/Tg+ 
mice, the thin filament pointed ends were the same distance 
from  the  Z-line  as  in  Tmod1
+/+  muscle,  as  determined   
by Tmod localization (Table I). We conclude that, in adult 
muscle, pointed-end capping by Tmod3 and -4 regulates the 
muscle-specific uniformity of thin filament lengths in the ab-
sence of Tmod1.
misaligned in embryonic skeletal muscles of both genotypes, 
this is characteristic of normal muscle development (Figs. 1–3 
and not depicted). These data confirm that Tmod1
/Tg+ mus-
cles lack an acute structural pathology.
To test the possibility that Tmod1 might play a role in 
the maintenance of thin filament length during use of adult 
muscle, we used distributed deconvolution to measure thin 
filament lengths (as determined by phalloidin staining for   
F-actin) and the position of the nebulin M1M2M3 domain in 
myofibrils from the EDL and soleus muscles of adult Tmod1
+/+ 
and Tmod1
/Tg+ mice. As in embryonic muscles, we found no 
significant effect of deleting Tmod1 on thin filament length or 
on the localization of the nebulin M1M2M3 domain in adult 
skeletal muscle (Table I). Therefore, the Tmod1-independent 
mechanism that specifies thin filament length in embryonic 
muscle persists into adulthood and is not compromised by 
muscle  use. Thin  filament  length  in  the  mouse  soleus  was 
0.1 µm longer than in the EDL regardless of the presence of 
Tmod1, which is consistent with previous studies that have 
shown that thin filament lengths are muscle specific and lon-
ger in slow as compared with fast muscles (Granzier et al., 
1991; Bang et al., 2006; Castillo et al., 2009).
Both Tmod3 and -4 substitute for Tmod1 
in adult skeletal muscle
We showed that Tmod4 but not Tmod3 could substitute for 
Tmod1 in embryonic muscle by capping thin filament pointed 
ends and correctly regulating thin filament length during myo-
fibrillogenesis (Fig. 3 and Table I). Therefore, we reasoned 
that a similar phenomenon might occur in adult muscle. Western 
Figure 4.  Tmod1 is dispensable for adult muscle structure. (A) TEM of 1-mo-old EDL muscle from Tmod1
+/+ and Tmod1
/Tg+ mice. (B–D) EDL muscle from 
Tmod1
+/+ and Tmod1
/Tg+ mice stained for F-actin and either -actinin (B), the C-terminal M160–164 domain of nebulin (C), or myomesin (D). Bars: (A) 
1 µm; (B–D) 3 µm.JCB • VOLUME 189 • NUMBER 1 • 2010   100
binding avidity of Tmod3 for striated muscle TMs as compared 
with Tmod1 and -4. Second, in Tmod1
/Tg+ muscle, Tmod3 
and -4 localize to thin filament pointed ends despite weaker 
binding, demonstrating that strong Tmod–TM binding is not   
required to correctly target Tmods to the pointed ends.
To further characterize Tmod–TM isoform interactions, 
we performed a reciprocal experiment to compare directly the 
relative binding of each Tmod to the different TMs, where blots 
containing the three aforementioned TMs were overlaid with 
Tmod1, -3, or -4. The results of this blot overlay show that both 
Tmod1 and -4 bound somewhat more strongly to slow-TM than 
to -TM but not at all to M9R slow-TM. In contrast, Tmod3 bound 
to M9R slow-TM to the same extent as to wild-type slow-TM 
and more poorly to -TM (Fig. 6, B, C, and E). The ability of 
Tmod3 but not Tmod1 or -4 to bind to M9R slow-TM sug-
gests that Tmod3 has divergent sequence requirements for TM 
binding. Our blot overlay data appear to contradict previous 
blot overlay and other binding experiments showing that resi-
dues 1–130 of chicken Tmod4 bind more strongly to N-terminal 
fast-TM peptides than do residues 1–130 of chicken Tmod1 
(Greenfield and Fowler, 2002). However, the truncated Tmods 
may be missing a portion of an additional TM-binding site 
(Kostyukova et al., 2006), thereby affecting the overall avidity 
of the Tmod–TM interaction. This confounding variable pre-
vents side by side comparison of the results in these two studies. 
In conclusion, the results of these blot overlays show that Tmod1 
binds most strongly to striated muscle TMs, with Tmod4 bind-
ing less well and Tmod3 displaying the weakest interaction. This 
Tmod1 binds to striated muscle TMs more 
strongly than Tmod3 or -4
We  speculated  that  the  absence  of  Tmod3  at  thin  filament 
pointed ends, which are capped by Tmod1 and -4 in Tmod1
+/+ 
muscle, might be caused by differences in Tmods’ avidities for 
TMs associated with thin filaments. To investigate this possibil-
ity, we performed blot overlay experiments to determine the 
relative binding strengths of Tmod1, -3, and -4 to the striated 
muscle TMs that are present on sarcomeric thin filaments in 
embryonic  and  adult  skeletal  muscles,  slow-TM  and  -TM 
(Gunning et al., 2008). Tmods bind to the N-terminal end of 
TMs (Sung and Lin, 1994; Vera et al., 2000; Greenfield and 
Fowler,  2002),  and  the  N-terminal  sequence  of  fast  striated 
muscle TM is identical to that of -TM (Stone and Smillie, 
1978; Helfman et al., 1986). In addition, M9R mutant slow-TM 
was used as a negative control for Tmod1 binding because it has 
been shown previously that Tmod1 does not bind to the M9R 
mutant slow-TM (Akkari et al., 2002; Ilkovski et al., 2008). To 
compare relative binding of each TM to the different Tmods, 
blots containing Tmods were overlaid with the three TMs. The 
results show that striated muscle TMs recognized Tmod1 better 
than they recognized Tmod3 or -4; when compared with Tmod1, 
both slow-TM and -TM bound more weakly to Tmod4 and 
almost not at all to Tmod3 (Fig. 6, A, C, and D). As expected, 
M9R slow-TM did not bind to Tmod1 or -4, although it did bind 
weakly to Tmod3 (Fig. 6, A, C, and D). These data indicate, 
first, that the absence of capping of thin filament pointed ends 
by Tmod3 in wild-type muscle can be explained by a lower 
Figure 5.  Tmod3 and -4 substitute for Tmod1 by capping thin filament pointed ends in adult skeletal muscle. (A) Western blots of 1-mo-old EDL muscle tis-
sue lysates show no apparent changes in Tmod3 or -4 levels in the absence of Tmod1. Tubulin and actin were loading controls. Molecular mass is indicated 
in kilodaltons. (B–D) EDL muscle from Tmod1
+/+ and Tmod1
/Tg+ mice stained for F-actin and either Tmod1 (B), -3 (C), or -4 (D). Bars, 5 µm.101 Tropomodulin isoform functions in skeletal muscle • Gokhin et al.
possibility, we subjected Tmod1
+/+ and Tmod1
/Tg+ mice to a 
battery of behavioral assessments. First, voluntary in-cage ac-
tivity was monitored by counting running wheel rotations and 
breaks of a laser beam passing through the cage. We found that 
Tmod1
/Tg+ mice exhibited a striking and statistically signifi-
cant reduction in voluntary activity (Fig. 8, A and B), which can 
be a symptom of muscle weakness. In contrast, Tmod1
/Tg+ 
mice did not show deficits in the hanging wire test or the grip 
strength test (Fig. 8, C and D). It is possible that the weakness 
varies in a muscle-specific manner, and the particular muscles 
recruited in the hanging wire and the grip strength tests were not 
sufficiently weakened to produce a statistically significant out-
come. The results of the rotarod test were the least conclusive, 
with Tmod1
/Tg+ mice showing a slight but statistically signifi-
cant trend toward reduced motor coordination at 4 and 6 mo   
of age but no differences at 1–2 mo or >12 mo (Fig. 8 E). One 
possibility is that this behavioral phenotype may have not yet 
manifested in >12-mo-old Tmod1
/Tg+ mice, whereas nor-
mal deterioration of wild-type muscles because of age may have 
obscured the effect of genotype in >12-mo-old mice. This could 
explain why this behavioral phenotype is most robust at the   
intermediate ages of 4 and 6 mo. However, it is important to 
note that the locomotor deficits in Tmod1
/Tg+ mice, as de-
termined by these behavioral assessments, may be caused by   
impaired neural function rather than acute muscle weakness. 
Given that Tmod1 is normally expressed in neurons in the brain 
indicates that altered Tmod–TM interactions permit correct reg-
ulation of thin filament length in skeletal muscle but raises the 
possibility that substitution of Tmod3 for Tmod1 may affect 
muscle function.
Deletion of Tmod1 depresses muscle 
contractility and locomotor behavior
To examine the functional effects of replacing the strong TM-
binding combination of Tmod1 and -4 with the weaker TM-
binding combination of Tmod3 and -4, we compared isometric 
contractility in skeletal muscle from Tmod1
+/+ and Tmod1
/Tg+ 
mice. Architectural experiments on fixed muscle tissue showed 
that the absence of Tmod1 did not affect physiological cross-
sectional area (PCSA; Fig. 7 A) or slack sarcomere length 
(Fig. 7 B), two important structural parameters. However,   
contractile tests on isolated EDL muscles from Tmod1
+/+ and 
Tmod1
/Tg+ mice revealed that muscles lacking Tmod1 produced 
20% less isometric force when supramaximally stimulated at 
100 Hz (Fig. 7 C). Normalization of isometric force to PCSA to 
compute isometric stress showed that muscles from Tmod1
/Tg+ 
mice indeed produced significantly less stress (Fig. 7 D), indi-
cating that the muscle function in Tmod1
/Tg+ mice is intrinsi-
cally compromised despite normal sarcomere structure (Fig. 4).
Because the absence of Tmod1 attenuates stress produc-
tion in skeletal muscle, we might expect Tmod1
/Tg+ mice   
to have more generalized locomotor deficits. To address this 
Figure 6.  Tmod3 and -4 bind to striated muscle TMs more weakly than does Tmod1. (A) Increasing amounts of Tmods were separated by SDS-PAGE, 
transferred to nitrocellulose, and overlaid with wild-type (WT) slow-TM (first row), M9R mutant slow-TM (second row), or -TM (third row). (B) Increasing 
amounts of TMs were separated by SDS-PAGE, transferred to nitrocellulose, and overlaid with Tmod1 (first row), -4 (second row), or -3 (third row). Parallel 
Coomassie-stained gels show loading (fourth row). (A and B) Molecular mass is indicated in kilodaltons. (C) Relative binding strengths among Tmods and 
TMs were scored semiquantitatively based on visual inspection of blots. Predicted binding between Tmods and fast-TM (parentheses) is based on sequence 
identity between the N-terminal regions of fast-TM and -TM where Tmods bind (Stone and Smillie, 1978; Helfman et al., 1986). Asterisks indicate 
conserved residues. The arrow shows the location of the nemaline myopathy–causing M9R mutation. (D and E) Binding avidities were quantified using 
densitometry by normalizing band intensities from the blots to the corresponding Coomassie-stained bands. x-axis labels refer to the protein that is overlaid, 
whereas data series refer to the immobilized protein. Note that relative binding avidities can only be compared within each individual blot overlay, demar-
cated by tick marks, and not from one TM to the next (in D) or from one Tmod isoform to the next (in E) because of variations in antibody binding and blot 
exposure times. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n = 4 lanes/group. Data are mean ± SEM. a.u., arbitrary unit.JCB • VOLUME 189 • NUMBER 1 • 2010   102
relative proportions of type 1 (slow) and type 2A/X/B (fast)   
fibers and whether slow or fast fibers exhibited preferential in-
creases in fiber size. In our strain of mice, wild-type TA and 
soleus are characterized by 5% and 17% of slow fibers, respec-
tively, which likely reflects the mouse strain mixed background 
of FVBN/129SVJ/C57Bl6 (McKeown et al., 2008). We found 
that both TA and soleus muscles from Tmod1
/Tg+ mice exhib-
ited an increased proportion of fast fibers at the expense of a   
decrease in slow fibers (Fig. 9 C). The muscle-wide increases in 
fiber cross-sectional area were driven mainly by increases in the 
size of fast fibers. Namely, the size of slow fibers was unchanged 
in Tmod1
/Tg+ TA and soleus muscles, but the size of fast fibers 
was significantly increased (Fig. 9 D). To confirm that fiber type 
changes correlate with MHC isoform changes, we used SDS-
PAGE to separate MHC isoforms and determine MHC isoform 
composition, and we found that Tmod1
/Tg+ muscles indeed 
exhibit a shift toward faster MHC isoform composition (Fig. 9 E). 
Finally, to ensure that weakness in Tmod1
/Tg+ muscles was 
not simply an artifact of acute muscle damage, we used Hoechst 
33258 staining to quantify the frequency of centralized nuclei in 
Tmod1
+/+ and Tmod1
/Tg+ muscles. The Tmod1
/Tg+ muscles 
did not exhibit a statistically significant increase in centralized 
nuclei (Fig. 9 F), indicating that Tmod1
/Tg+ mice do not have 
an increased propensity for muscle damage that would lead to 
cycles  of  muscle  degeneration/regeneration.  Together,  these 
data indicate that the Tmod1
/Tg+ mouse is a novel model of 
decreased muscle use characterized by fast fiber hypertrophy.
Discussion
In this study, we demonstrate that Tmod3 and -4 can replace the 
thin filament pointed-end capping function of Tmod1 in devel-
opmentally distinct ways. First, in embryonic muscle, Tmod4 
(but not Tmod3) caps pointed ends in the absence of Tmod1, al-
lowing myofibril assembly and thin filament length regulation. 
Second, both Tmod1 and -4 normally cap pointed ends and reg-
ulate thin filament lengths in adult muscle, but the recruitment 
of Tmod3 to the pointed ends in the absence of Tmod1 corre-
lates with depressed isometric stress production. Therefore, 
Tmod1 appears dispensable for establishing and maintaining 
the correct thin filament lengths and structure of skeletal mus-
cle. However, impaired isometric contractility in the absence of 
Tmod1 leads to systemic functional deficits in skeletal muscle 
and reprograms fibers toward a faster phenotype. Thus, Tmod1 
regulates skeletal muscle physiology in a thin filament length–
independent manner. This is the first study to show that Tmod 
isoforms can structurally but not functionally compensate for 
one another in vivo.
Tmod1 is essential for myofibril assembly 
and development in cardiac but not  
skeletal muscle
Previous work has shown a key role for Tmod1 in cardiac myo-
fibril assembly and development. Tmod1-null cardiomyocytes in 
the embryonic mouse heart completely fail to assemble myofibrils 
and do not beat, resulting in failure of cardiac looping and aborted 
development (Fritz-Six et al., 2003; McKeown et al., 2008).   
(Cox and Zoghbi, 2000; Yao et al., 2007) and, therefore, is not 
present in the neurons of Tmod1
/Tg+ animals (unpublished 
data), this possibility cannot be excluded.
Deletion of Tmod1 produces fast  
fiber hypertrophy
It is well established that the level of muscle use directly affects 
the fiber type composition within a muscle, with heavily re-
cruited muscles trending toward a slower and smaller fiber com-
position and infrequently recruited muscles trending toward a 
faster and larger fiber composition (Lieber, 2010). To investi-
gate whether the reduced isometric contractility and impaired 
locomotor behavior in Tmod1
/Tg+ mice correlated with fiber 
type changes, we compared the fiber properties of Tmod1
+/+ and 
Tmod1
/Tg+ muscles. We found that mean fiber cross-sectional 
areas in TA and soleus muscles from Tmod1
/Tg+ mice were 
100 µm
2 larger than normal (Fig. 9, A and B), leading us to 
believe  that  a  faster  fiber  phenotype  might  also  be  present. 
Therefore, we used myosin ATPase staining to determine the 
Figure 7.  Deletion of Tmod1 depresses skeletal muscle contractile func-
tion. (A and B) Muscle PCSA (A) and slack sarcomere length (B) are un-
changed in Tmod1
/Tg+ mice. (C and D) Isometric force (C) and isometric 
stress (D) produced by EDL muscle from Tmod1
/Tg+ mice are significantly 
decreased. *, P < 0.05; ***, P < 0.001. n = 8 muscles/genotype. Data 
are mean ± SEM.103 Tropomodulin isoform functions in skeletal muscle • Gokhin et al.
inventories and the expression of nebulette versus nebulin in 
cardiac and skeletal muscle, respectively, may underlie these 
features of cardiac versus skeletal myofibril assembly (Moncman 
and  Wang,  1995;  Millevoi  et  al.,  1998; Almenar-Queralt   
et al., 1999b; Cox and Zoghbi, 2000; Conley et al., 2001; Ono 
et al., 2005).
Tmods and TMs regulate thin filament 
structure at the pointed end
The  lack  of  thin  filament  length  changes  in  the  absence  of 
Tmod1 provides important insights regarding the functions of 
Tmods at thin filament pointed ends. Tmod1 is a dynamic cap, 
with Tmod1 moving between its bound (“on”) and unbound 
(“off”) states (Littlefield et al., 2001). The proportion of time 
that Tmods spend capping the thin filament is expected to de-
pend on their avidities for TM-decorated thin filaments. There-
fore, we initially considered two possible outcomes of Tmod1 
deletion. (1) Thin filaments could lengthen because of a lack of 
pointed-end capping, allowing new actin subunits to associate 
with the filament. This outcome would be consistent with the 
results of Tmod1 antibody inhibition experiments (Gregorio et al., 
1995) and perturbations of Tmod1 expression levels in cultured 
cardiomyocytes (Sussman et al., 1998a; Littlefield et al., 2001) 
and  in  Drosophila  melanogaster  (Mardahl-Dumesnil  and 
Instead, actin polymerizes into aberrant aggregates and bundles, 
suggesting a critical early role for Tmod1 in the in vivo thin fila-
ment and myofibril assembly pathway (Chu et al., 2003; Fritz-Six 
et al., 2003). Further support for a critical role for Tmod1 in 
cardiac myofibril assembly is that Tmod1-null embryonic stem 
cells induced to differentiate into cardiomyocytes assemble 
only a very few myofibrils that are wispy, smaller, and less or-
ganized (Ono et al., 2005). Our data argue that, unlike in cardiac 
myofibrils, Tmod1 is not necessary for the assembly of skeletal 
myofibrils or for skeletal muscle development. Even in the ab-
sence of Tmod1, myoblasts successfully fuse into myotubes, 
neighboring myotubes align and orient into functioning muscle 
tissues, and myofibrils assemble completely (Fig. 1 and Fig. S1). 
Our data also show that Tmod1 is not required for fine-tuning 
thin filament lengths, both during and after myofibril assembly 
(Table I). Because Tmod1-null cardiomyocytes fail to assemble 
myofibrils (Fritz-Six et al., 2003; McKeown et al., 2008) but 
Tmod1-null skeletal myocytes exhibit no such defect, we can 
conclude  that  the  mechanisms  of  myofibril  assembly  in  the 
heart and in skeletal muscle are different, with Tmod1 playing 
distinct roles in these different processes. This conclusion is 
also supported by previous studies in cultured muscle cell mod-
els (Gregorio and Fowler, 1995; Almenar-Queralt et al., 1999a; 
Gregorio and Antin, 2000). Differences in the Tmod isoform   
Figure 8.  Deletion of Tmod1 impairs locomotor activity in mice. (A and B) Voluntary activity in 5–7-mo-old mice was monitored over three consecutive 
light cycles (12 h off and 12 h on). The number of wheel counts and laser beam breaks was substantially lower in Tmod1
/Tg+ animals. (C and D) Muscle 
strength in mice of various ages was assessed using the hanging wire and grip strength tests. No significant differences in time before falling or grip force 
were found at any age. (E) Motor coordination was assessed using the rotarod test. No differences in angular speed before falling were found in 1–2-mo-
old animals and >12-mo-old animals, but a slight decrease in coordination is evident in 4- and 6-mo-old Tmod1
/Tg+ animals. *, P < 0.05; **, P < 0.01; 
***, P < 0.001. n = 6 (in A and B) or n = 8 (in C–E) mice/genotype. Data are mean ± SD.JCB • VOLUME 189 • NUMBER 1 • 2010   104
these outcomes occurred in mouse skeletal muscle (Table I). In-
stead, we uncovered a novel third outcome, that thin filament 
lengths were unaffected as the result of replacement by other 
Tmod isoforms, namely Tmod3 and -4, despite the fact that 
these Tmods bind to striated muscle TMs more weakly than 
Tmod1 (Fig. 6). Thus, Tmod1
/Tg+ skeletal muscle represents a 
Fowler, 2001; Bai et al., 2007). (2) Alternatively, thin filaments 
could shorten because of dissociation of TM from the thin fila-
ment and resultant thin filament instability and depolymeriza-
tion (Broschat, 1990; Weber et al., 1994). This has been shown 
to occur after antibody inhibition of the Tmod–TM interaction 
in cultured cardiomyocytes (Mudry et al., 2003). Neither of 
Figure 9.  Deletion of Tmod1 shifts muscle fiber types toward a faster distribution. (A) The distribution of fiber sizes in the TA was shifted rightward in 
Tmod1
/Tg+ muscle. Graph shows the size distribution of n = 560 Tmod1
+/+ fibers and n = 479 Tmod1
/Tg+ fibers measured from n = 2 mice/genotype. 
(B) The mean fiber cross-sectional area was significantly elevated in both the TA and soleus, suggesting a faster fiber type. (C) The proportion of type 
2A/X/B fibers was elevated in the TA and soleus of Tmod1
/Tg+ mice at the expense of type 1 fibers. (D) Although there were no significant differences   
in the size of type 1 fibers, type 2A/X/B fibers were significantly larger in Tmod1
/Tg+ TA and soleus. (E) TA and soleus tissue lysates were separated on 
8% SDS-PAGE gels. In both TA and soleus, a shift toward faster MHC isoforms was evident in Tmod1
/Tg+ mice. Molecular mass is indicated in kilodaltons. 
(F) No significant differences in centralized nuclei were observed between Tmod1
+/+ and Tmod1
/Tg+ muscle. *, P < 0.05; **, P < 0.01; ***, P < 0.001. 
n = 4 (in C and D) or n = 8 (in B, E, and F) muscles/genotype. Data are mean ± SEM.105 Tropomodulin isoform functions in skeletal muscle • Gokhin et al.
duction at varying degrees of thin and thick filament overlap 
(Gordon et al., 1966; Granzier et al., 1991). As thin filament 
length increases or decreases, optimal sarcomere length for 
muscle force production is expected to increase or decrease,   
respectively. This property of skeletal muscle has been demon-
strated directly in vivo in adult fish, in which fast- and slow-
twitch muscles have distinctly different thin filament lengths 
(Granzier et al., 1991). This property has also been demon-
strated in nebulin-null mice, whose skeletal muscle thin fila-
ments are substantially shorter and produce optimal force at a 
shorter sarcomere length compared with their wild-type coun-
terparts (Gokhin et al., 2009; Ottenheijm et al., 2009). Based on 
these previous experiments, and the fact that thin filaments from 
Tmod1-null muscles are of normal length (Table I), we con-
clude that the optimal sarcomere length range for force produc-
tion does not differ between Tmod1
+/+ and Tmod1
/Tg+ muscles. 
Despite this, the absence of Tmod1 depresses isometric stress 
production and locomotor behavior, resulting in alterations in 
muscle fiber type composition and size consistent with fast fiber 
hypertrophy (Figs. 7–9). Our myosin ATPase staining measure-
ments show that the increase in fiber size in Tmod1
/Tg+ mus-
cles is restricted mainly to fast fibers. Because mouse muscles 
are overwhelmingly composed of fast fibers even under normal 
circumstances (Burkholder et al., 1994), changes in fast fibers 
likely drive the fiber type and size shifts that occur in the ab-
sence of Tmod1 (Fig. 9). Thus, our data indicate that the   
absence of Tmod1 produces fast fiber hypertrophy in a thin 
filament length–independent manner and, thus, that Tmod1 
must regulate skeletal muscle physiology via other mechanisms. 
However, we cannot exclude the possibility that some aspects of 
the Tmod1
/Tg+ skeletal muscle phenotype may be secondary 
effects of Tmod1 deletion from neurons and resultant altera-
tions in motoneural input, leading to fiber type switching and/or 
behavioral effects (Lieber, 2010).
What aspects of muscle contraction aside from thin fila-
ment length regulation might be compromised in the absence of 
Tmod1? One possibility is that Tmod1 modulates actomyo-
sin cross-bridge formation through its interaction with TM at 
the pointed end. Therefore, in the absence of Tmod1, together 
with replacement by weaker TM-binding Tmods, TM may not 
undergo the appropriate conformational changes to permit 
productive actomyosin cross-bridge cycling. Although this pos-
sibility is intriguing, it would require that Tmod1 have a long-
range effect along the entire thin filament rather than acting just 
at the pointed end. It is equally possible that Tmod1 plays a role 
in coupling mechanical force between myofibrils and the sarco-
lemma through its association with the extrasarcomeric actin 
cytoskeleton. Actin filaments are known to associate with costa-
meres, which are multiprotein complexes that establish a link 
between the sarcolemma and peripheral myofibrils (Craig and 
Pardo, 1983; Rybakova et al., 2000). Indeed, Tmod1 has been 
shown to colocalize with 2-spectrin in the costameres of fast 
muscle fibers in the chicken, suggesting that it may cap actin 
filaments in the muscle membrane skeleton (Almenar-Queralt 
et al., 1999b). It is conceivable that misregulation of costameric 
actin filament length or stability in the absence of Tmod1 leads 
to mechanical decoupling of peripheral myofibrils from the   
novel system of reduced thin filament capping without concom-
itant thin filament length changes. What could account for a re-
duction in pointed-end capping without concomitant changes in 
thin filament length? One possibility is that a subset of pointed 
ends is uncapped in the absence of Tmod1, whereby substoi-
chiometric amounts of other Tmod isoforms maintain thin fila-
ment lengths by rapidly shuttling among adjacent thin filaments. 
Alternatively, Tmod1
+/+ muscle may contain an excess of Tmod3 
or -4 that is engaged on pointed ends only when Tmod1 is not 
present. In Tmod1
/Tg+ muscle, thin filaments that are normally 
capped by Tmod1 may be capped by Tmod3 (in the adult) or by 
Tmod4 (in both the embryo and the adult) upon Tmod3 or -4 
translocation from the sarcoplasm to the pointed ends. In either 
case, the overall level of pointed-end capping by these different 
combinations of Tmod isoforms appears to be sufficient to pre-
vent net actin elongation or shortening from the pointed ends in 
skeletal muscle. We also cannot exclude the possibility that Tmods 
do not play any role in skeletal muscle thin filament length 
specification, and as-yet-unknown factors interact with Tmods, 
TM, nebulin, and actin to determine length, but pursuing such a 
model is beyond the scope of this work.
Nebulin is not a thin filament ruler
This study extends the previous study that nebulin is not a mo-
lecular ruler that dictates thin filament length (Castillo et al., 
2009). Instead, thin filaments extend beyond the nebulin N ter-
minus and establish a nebulin-free pointed-end extension whose 
length ultimately determines the total thin filament length (Castillo 
et al., 2009; this study). The previous study analyzed an assort-
ment of skeletal muscles from adult rabbits and found that thin 
filament length varied from 1.13 to 1.31 µm, as determined by 
Tmod localization (Castillo et al., 2009). In our study, Tmod 
distances from the Z-line ranged from 1.11 µm in the EDL, to 
1.22 µm in the soleus, to 1.26 µm in the embryonic flank, which 
is consistent with lengths found in rabbit and mouse muscles 
(Bang et al., 2006; Castillo et al., 2009). We also observed that 
the nebulin M1M2M3 domain was located at a relatively fixed 
distance 0.84–0.90 µm from the Z-line (Table I), which is 
closer to the Z-line than Tmod. Thus, we are able to confirm that 
a nebulin-free pointed-end actin extension determines muscle-
specific thin filament lengths (Castillo et al., 2009). Paradoxi-
cally, the N terminus of nebulin contains a Tmod1-binding site 
(McElhinny et al., 2001), even though thin filaments elongate 
and Tmod1 caps pointed ends 200–400 nm away from the 
nebulin N terminus (Castillo et al., 2009; this study). Therefore, 
nebulin may only interact with Tmod1 at particular stages of 
skeletal muscle myofibril assembly or developmental junctures 
that have not yet been identified. Alternatively, the nebulin   
N terminus might act at a distance to modulate pointed-end cap-
ping by Tmod1 (Fowler et al., 2006).
Tmod1 is a novel regulator of skeletal 
muscle physiology
Correct specification of thin filament length in skeletal muscle 
has important functional implications. Thin filament length is one 
of the principal determinants of the sarcomere length–tension 
relationship, which quantitatively describes muscle force pro-JCB • VOLUME 189 • NUMBER 1 • 2010   106
stripped, and reprobed again with monoclonal antibodies against actin 
(C4; 1:10,000; a gift from J.L. Lessard, University of Cincinnati, Cincinnati, 
OH), both diluted in Blitz, followed by HRP-conjugated anti–mouse second-
ary antibodies (1:5,000; Invitrogen) and detection by ECL. Each lane in 
the Western blots is from a muscle obtained from a different individual 
embryo or adult animal.
Blot overlay
Purified Tmod proteins used were recombinant chicken Tmod1 (Fowler   
et al., 2003), chicken Tmod4 (Almenar-Queralt et al., 1999b), and human 
Tmod3 (Fischer et al., 2003). Purified striated muscle TM proteins used 
were recombinant human slow-TM, M9R slow-TM, and -TM (gifts from   
S.T. Cooper [University of Sydney, Sydney, New South Wales, Australia] 
and N.G. Laing [University of Western Australia, Perth, Western Australia, 
Australia]) expressed in baculovirus and purified as described previously 
(Akkari et al., 2002). Increasing amounts of purified Tmods or TMs were 
dissolved in SDS sample buffer and separated by SDS-PAGE on 12 or 15% 
mini-gels (Laemmli, 1970). Parallel gels were stained with Coomassie blue 
or transferred to nitrocellulose, and Tmod or TM binding was assessed   
using a blot overlay (Fowler, 1987). Transferred proteins were bound to 
the membrane by incubating the nitrocellulose in PBS for 1 h at 65°C, fol-
lowed by two 5-min washes at 4°C in OverWash buffer (80 mM KCl,   
2 mM MgCl2, 1 mM EGTA, 0.2% Triton X-100, and 20 mM Hepes, pH 7.3). 
The blots were then incubated for 12–18 h at 4°C with 1–2 µg/ml of puri-
fied Tmods or TMs in OverWash supplemented with 2% BSA, and excess 
protein was rinsed with five 5-min washes with OverWash. Bound Tmods 
or TMs were detected by incubating blots for 12–18 h at 4°C with, as indi-
cated, mouse monoclonal anti-Tmod1 (mAb95; 1 µg/ml; Almenar-Queralt 
et al., 1999a,b), affinity-purified rabbit anti–chicken Tmod4 (2 µg/ml; 
Almenar-Queralt et al., 1999b), rabbit antisera to human Tmod3 (R5168; 
1:100; Fischer et al., 2003), or rabbit polyclonal antibodies to human 
erythrocyte TMs (R14; Ursitti and Fowler, 1994). Blots were then rinsed 
with two consecutive OverWash rinses followed by five 10-min shaking 
washes.  HRP-conjugated  mouse  or  rabbit  secondary  antibodies  were 
added for 1 h in Blotto (185 mM NaCl, 0.05% Tween 20, 3% powdered 
skim milk, and 50 mM Tris, pH 7.5). Blots were subsequently washed twice 
in Blotto and twice in Otto (Blotto minus milk) followed by detection by ECL. 
Gels and blots were quantified in ImageJ (National Institutes of Health). 
Note that solid phase blot overlay binding assays are irreversible and do 
not  report  affinity  (Kd)  but  rather  the  avidity  of  Tmod–TM  interactions 
(Friguet et al., 1985).
Immunofluorescence staining
Timed pregnant mice were sacrificed, and E15.5 embryos were dissected 
from the uterus in Dulbecco’s PBS (D-PBS) for immunofluorescence. Em-
bryos were fixed for 24–48 h at 4°C in 4% PFA in D-PBS, passed through 
consecutive incubations in 1, 5, and 20% sucrose in D-PBS, embedded in 
OCT (optimum cutting temperature) medium, cryosectioned, and mounted 
on microscope slides. Adult TA, diaphragm, EDL, and soleus muscles were 
dissected from 1-mo-old mice, immersed in ice-cold relaxing buffer (100 mM 
NaCl, 2 mM KCl, 2 mM MgCl2, 6 mM K3PO4, 1 mM EGTA, and 0.1% 
glucose, pH 7.0), stretched, fixed in 4% PFA, dehydrated in sucrose steps, 
embedded in OCT medium, snap frozen in liquid N2, cryosectioned, 
and mounted on slides. All sections were washed in PBST (D-PBS + 0.1% 
Triton X-100) and blocked for at least 4 h in 4% BSA + 1% goat serum in 
PBST. Sections were labeled with primary antibodies diluted in blocking 
buffer overnight at 4°C, washed in PBST, and then labeled with a fluores-
cently conjugated secondary antibody mixture in blocking buffer for 2 h at 
room temperature. The secondary antibody mixture was supplemented 
with either Alexa Fluor 546–phalloidin or rhodamine-phalloidin (1:200; 
Sigma-Aldrich) to stain F-actin. Antibodies were as follows: affinity-purified 
rabbit polyclonal anti–human Tmod1 (R1749; 3–5 µg/ml), rabbit poly-
clonal antisera to human Tmod3 (R5168bl3c; 1:100) or chicken Tmod4 
(R3577bl3c; 1:50), affinity-purified rabbit polyclonal anti–nebulin N-terminal 
M1M2M3  domain  (1357L)  and  anti–C-terminal  M160–164  domain 
(both at 10 µg/ml; gifts from C.C. Gregorio, University of Arizona,   
Tucson, AZ; McElhinny et al., 2005), mouse monoclonal anti–-actinin 
(EA53;  1:200;  Sigma-Aldrich)  and  antimyomesin  (B4;  1:1,000;  a  gift 
from E. Ehler, Kings College London, London, England, UK), Alexa Fluor 
488–conjugated goat anti-rabbit IgG (1:200; Invitrogen), and Alexa Fluor 
647–conjugated goat anti–mouse IgG (1:200; Invitrogen). Images of sin-
gle optical sections were collected at room temperature on a laser-scanning 
confocal  microscope  (Radiance  2100;  Bio-Rad  Laboratories)  mounted   
on a microscope (TE2000-U; Nikon) using 20× NA 0.75 air (Fig. S1) or 
100× NA 1.4 oil (Figs. 1–3) objective lenses using LaserSharp 2000 (Bio-
Rad Laboratories) or on a confocal microscope (LSM 710; Carl Zeiss, Inc.) 
sarcolemma and reduces the effective stress produced by the 
entire muscle. This would be consistent with Tmod1’s role in 
controlling the organization and establishing the mechanical in-
tegrity of the membrane-associated spectrin–actin network in 
other cell types, including lens fiber cells (Nowak et al., 2009) 
and erythrocytes (unpublished data). Future work will focus on 
deciphering Tmod1’s precise function in regulating the mechan-
ics of skeletal muscle contraction.
Materials and methods
Experimental animals
A viable Tmod1-null mouse line was generated by crossing Tmod1
lacZ+/ 
mice (Fritz-Six et al., 2003) with mice that express a Tmod1 transgene un-
der control of the cardiac -MHC promoter (Tg(-MHC–Tmod1), denoted 
as Tg+ in the text), as previously described in detail (McKeown et al., 
2008). Tmod1-null mice with the Tg(-MHC–Tmod1) transgene express 
Tmod1 exclusively in the heart and in no other tissues and survive into 
adulthood (McKeown et al., 2008; Nowak et al., 2009). These mice had 
a  mixed  FVBN/129SVJ/C57Bl6  background  and  were  maintained  as   
heterozygotes  (Tmod1
+/Tg+).  Phenotypic  analysis  was  performed  on 
Tmod1
+/+, Tmod1
+/+Tg+, and Tmod1
/Tg+ progeny generated from inter-
crosses of Tmod1
+/Tg+ and Tmod1
+/ mice. In some experiments, inter-
crosses of Tmod1
/Tg+ mice were performed to increase the number of 
Tmod1
/Tg+ progeny. No phenotypic differences were observed between 
Tmod1
+/+ and Tmod1
+/+Tg+ skeletal muscle, so data from these animals 
were pooled and referred to in the text as Tmod1
+/+ for simplicity. Geno-
typing was performed by PCR as described previously (McKeown et al., 
2008). All procedures were performed in accordance with animal care 
guidelines enforced by the Institutional Animal Care and Use Committee at 
The Scripps Research Institute.
Western blotting
For  Tmod1  and  -4  Western  blots,  rabbit  antibodies  generated  against   
human Tmod1 (R1749) were affinity purified and used at 1 µg/ml (Fowler, 
1990), whereas rabbit antisera generated against chicken Tmod4 (R3577; 
Almenar-Queralt et al., 1999b) were preadsorbed by passing through a 
human Tmod1 column, and the flow-through was used at a dilution of 
1:250. Embryonic and adult muscles were dissected and extracted by 
homogenization in 4 vol (vol/wet weight) of 9.2 M urea followed by solu-
bilization in 1/5 vol of 5× SDS sample buffer and boiling 5 min. Proteins 
were separated on 8–16% gradient SDS-PAGE Tris-glycine mini-gels (Invit-
rogen; Laemmli, 1970). Parallel gels were stained with Coomassie blue or 
transferred to nitrocellulose for Western blotting (Fowler, 1990). Blots were 
blocked in 4% BSA in PBS (10 mM NaHPO4, pH 7.4, 150 mM NaCl, and 
1 mM EDTA) at room temperature for 2 h and then incubated with primary 
antibodies diluted in Blitz buffer (4% BSA, 10 mM NaHPO4, pH 7.4, 150 mM 
NaCl, 1 mM EDTA, and 0.2% Triton X-100) at room temperature for 4 h. 
After washing in PBS + 0.2% Triton X-100, blots were incubated in HRP-
conjugated goat anti–rabbit IgG (1:5,000; Invitrogen) diluted in Blitz for 1 h 
at 4°C and detection by ECL.
For  Tmod3  Western  blots,  rabbit  antibodies  generated  against   
human Tmod3 (R5168; Fischer et al., 2003) were preadsorbed by pas-
sage of antisera through a human Tmod1 column followed by affinity puri-
fication on a mouse Tmod3 column and elution with 4 M MgCl2. Antibodies 
were dialyzed into PBS followed by dialysis into 50% glycerol in PBS and 
stored at 20°C. Because of the susceptibility of Tmod3 to proteolysis, em-
bryonic and adult muscles were snap frozen in liquid N2 and pulverized 
on dry ice. Tissues were homogenized in 10 vol of 1× SDS sample buffer 
(vol/wet weight tissue), sonicated, and boiled for 5 min. Embryonic muscle 
samples were further passed through 16-, 25-, and 30-gauge needles until 
viscosity was reduced. Aliquots were stored at 80°C and used only once 
after thawing. Proteins were separated on gradient gels followed by trans-
fer to nitrocellulose as described in the previous paragraph. Blots were 
blocked by incubation in 4% BSA + 2% donkey serum in PBS overnight at 
4°C. Blots were then incubated in primary antibody diluted in 2% donkey 
serum in Blitz for 2 h at room temperature. After washing, blots were incu-
bated  in  HRP-conjugated  donkey  anti–rabbit  IgG  (1:5,000;  Invitrogen)   
diluted in 2% donkey serum in Blitz for 2 h at 4°C, and bands were de-
tected by ECL.
To control for loading, all blots were stripped and reprobed with 
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voltages, beginning with 5 V, until maximum twitch force was achieved 
(typically at 8 V). Voltage was then doubled to guarantee recruitment of 
all fibers. Maximum isometric force was elicited by applying a 400-ms 
train of 0.3-ms pulses delivered at 100 Hz while maintaining constant Lm. 
A computer algorithm in LabVIEW (National Instruments) was used to trig-
ger the stimulator, acquire signals from the force transducer, and analyze 
all force–time records. After testing, the muscle was removed from the 
chamber and weighed. To determine the longitudinal stress within the mus-
cle, force was normalized to PCSA, an anatomical parameter whose value 
is directly proportional to force-generating capacity (Lieber and Fridén, 
2000). Lf was determined for each muscle by multiplying Lm by the charac-
teristic fifth toe EDL Lf:Lm ratio of 0.69 (Chleboun et al., 1997). Muscle mass 
(M in milligrams), muscle density ( = 1.056 g/cm
3), fiber pennation angle 
( = 11.3°), and Lf were used to compute PCSA (in millimeters squared), 
which is equal to (Mcos)/(Lf). The constants in this formula have been 
published previously (Mendez and Keys, 1960; Chleboun et al., 1997). 
Differences between genotypes were detected using the Student’s t test.
Behavioral testing
Behavioral characteristics were analyzed at the Mouse Animal Models 
Core  at  The  Scripps  Research  Institute  (http://www.scripps.edu/cnad/
inia/animalmodelcores.html). At least six mice per genotype were in all 
experimental groups. Voluntary in-cage activity of singly housed 5–7- 
mo-old mice was monitored using an integrated Comprehensive Labora-
tory Animal Monitoring System (CLAMS; Columbus Instruments). Testing 
occurred in clear respiratory chambers (20 × 10 × 12.5 cm) equipped 
with a sipper tube delivering water, food tray connected to a balance, 16 
photobeams situated in rows at 0.5-in intervals to detect motor activity, and 
a running wheel with rotation monitoring. Data were averaged across 12-h 
intervals corresponding to circadian lights off and lights on epochs. Muscle 
strength was measured in 1–2-, 4-, 6-, and >12-mo-old mice using the 
hanging wire and grip strength tests. In the hanging wire test, mice were 
held so that only their forelimbs contacted an elevated metal bar, and la-
tency to fall was measured up to a maximum of 30 s. The hanging wire test 
was repeated three times with 30-s rest periods. In the grip strength test, 
muscle grip force was measured in the forelimbs using a dual-digital grip 
strength meter with mesh pull bars (Columbus Instruments). Each mouse 
was first allowed to grip the instrument grid with only its front paws, and 
then the mouse was gently and steadily pulled back until the grip was   
released, at which moment the maximal grip strength was recorded by the 
instrument. This grip strength test was repeated four times with 30-s rest pe-
riods. Coordination was measured using the rotarod test with an Roto-Rod 
Series 8 (IITC Life Sciences). Mice were placed on the stationary rod, 
which began to accelerate from 10 rpm, and the rpm at fall was recorded. 
Mice were subjected to six testing bouts per day, which consisted of two 
sets of three bouts each, with 1 min between each bout and 2 h between 
each set. The rotarod procedure was repeated across 2 d. Differences   
between genotypes were detected using the Wilcoxon rank-sum test.
Muscle fiber types and sizes
For determination of fiber type composition, muscles were homogenized in 
ice-cold homogenization buffer (250 mM sucrose, 100 mM KCl, 5 mM 
EDTA, and 20 mM Tris, pH 6.8), and protein was then diluted in SDS sam-
ple buffer and boiled for 2 min. MHC isoforms were separated on 22-cm-
long 8% SDS-PAGE gels and silver stained (Talmadge and Roy, 1993). 
Densitometry was performed to quantify bands and compute isoform distri-
butions using ImageJ. The sequence of MHC isoforms 1, 2A, 2X, and 2B 
reflects increasing twitch speed. To measure mean fiber size, transverse 
muscle cryosections were blocked with 1% BSA followed by a combination 
of 1.5% normal goat serum and 10% normal rat serum and immuno-
labeled  overnight  with  polyclonal  antilaminin  (1:1,000;  Sigma-Aldrich) 
and then for 1 h with Alexa Fluor 594–conjugated goat anti–rabbit IgG 
(Invitrogen) supplemented with Hoechst 33258 to locate centralized nuclei.   
Images were collected at room temperature with a digital camera (SPOT 
RT; Diagnostic Instruments, Inc.) on an epifluorescent microscope (Micro-
phot SA; Nikon) using a 10× NA 0.30 air objective lens. Fiber sizes in 
laminin-immunostained images were measured using a custom-made ap-
plet  that  thresholded  images  and  computed  fiber  cross-sectional  areas 
(Gokhin et al., 2008). To determine fiber size distribution, dissected mus-
cles were immersion fixed in 4% PFA and processed for embedding in par-
affin by standard procedures. Paraffin sections were cut in the transverse 
orientation and stained with hematoxylin and eosin (H&E). For myosin 
ATPase staining (Brooke and Kaiser, 1970), transverse cryosections were 
preincubated in acidic conditions (pH 4.3), rinsed, and then incubated at 
37°C in the presence of ATP and Ca
2+, pH 9.75. Sections were then incu-
bated in 2% CoCl2, rinsed, and reacted with 0.5% (NH4)2S. H&E- and   
using 100× NA 1.4 oil objective lenses, zoom 1 (Fig. 4 B) or zoom 2   
(Fig. 4, C and D; Fig. 5; and Fig. S3), and using ZEN 2008 (Carl Zeiss, 
Inc.). Images were processed with Photoshop (Adobe), and image figures 
were constructed in Illustrator (Adobe).
EM
Mice were perfusion fixed in 4% PFA + 1.5% glutaraldehyde in 0.1 M 
cacodylate buffer on ice followed by dissection of soleus and EDL muscles 
and incubation for several hours in the same fixative. Fixation was contin-
ued overnight in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, and tis-
sues were washed in cacodylate buffer, fixed further in 1% OsO4 in 0.1 M 
Na cacodylate buffer for 2 h, again washed in cacodylate buffer, and then 
dehydrated in graded ethanols followed by propylene oxide and embed-
ded in EMbed 812/Araldite (Electron Microscopy Sciences). Thick sec-
tions (1–2 µm) were cut, mounted on glass slides, and stained in toluidine 
blue for assessment of tissue structure and preservation in the light micro-
scope. Subsequently, 60-nm thin sections were cut, mounted on copper slot 
grids coated with Parlodion, and stained with uranyl acetate and lead   
citrate for examination on a transmission electron microscope (Philips 
CM100; FEI) at 80 kV. Images were collected using a charge-coupled   
device camera (Megaview III; Olympus).
Distributed deconvolution analysis
Measurements of thin filament lengths in phalloidin-stained myofibrils, as 
well as the positions of Tmods and N-terminal M1M2M3 epitopes of nebu-
lin relative to the Z-line, were performed using the distributed deconvolu-
tion method (Littlefield and Fowler, 2002). This technique uses a plugin 
developed for ImageJ that generates the best fit of a model intensity distri-
bution function for a given thin filament component (Tmod, F-actin, and 
nebulin M1M2M3 domain) to an experimental 1D myofibril fluorescence 
intensity profile (line scan) obtained for each fluorescent probe (anti-Tmod, 
fluorescent phalloidin, and anti–nebulin M1M2M3). The plugin estimates 
the spread of light along the line scan and the positions and intensities of 
each  probe  with  adjustable  intensity  distributions,  using  probe-specific 
models for a repeating series of three to five thin filament arrays along a 
given myofibril. Image regions containing adequately stretched sarcomeres 
were identified based on the presence of Tmod or nebulin M1M2M3 dou-
blets or gaps in the phalloidin signal (H-zones). A background-corrected 
line scan was calculated by averaging the intensity across the width of the 
myofibril for each point along the selected myofibril length and then sub-
tracting the minimum intensity adjacent to the myofibril from the mean in-
tensity across the myofibril width. Line scans were analyzed by distributed 
deconvolution using model distributions for phalloidin, Tmod, and nebulin 
M1M2M3. Thin filament length determined from fluorescent phalloidin line 
scans was approximately located at the half-maximal intensity on the shoul-
ders of the phalloidin signal with respect to the Z-line. The distances of 
Tmods and nebulin M1M2M3 from the Z-line were equal to half the dis-
tance between the peaks on either side of the thin filament array. Distances 
in micrometers were calculated by converting pixel sizes to micrometers 
based on the magnification factor for each image (0.04492 µm/pixel). 
Tmod lengths were determined using both Tmod1- and Tmod4-immuno-
stained images in Tmod1
+/+ animals but only Tmod4-immunostained im-
ages in Tmod1
/Tg+ animals. Note that measurements based on phalloidin 
staining resulted in shorter lengths than measurements based on Tmod 
staining because of systematic differences in the shapes of the thin filament 
model profiles that are convolved with Gaussian distributions to estimate 
the point spread functions of the different fluorescent probes (Littlefield and 
Fowler, 2002). Differences between genotypes were detected using the 
Student’s t test.
Physiological testing
Contractile tests were performed on the fifth toe belly of the EDL, which was 
selected for its fiber length (Lf) homogeneity and robust tendons (Chleboun 
et al., 1997). The fifth toe belly of the EDL was excised in ice-cold mamma-
lian Ringer’s solution and transferred to a customized muscle-testing appa-
ratus (Sam et al., 2000). The distal tendon was tied down with silk sutures 
to a rigid post interfaced with dual-mode ergometer (Aurora Scientific). The 
proximal tendon was secured, also with silk sutures, to a rigid frame   
attached to a horizontally adjustable platform. Muscle length (Lm) was ad-
justed such that mechanical slack was eliminated, and laser diffraction 
verified slack sarcomere length (3.0 µm). Lm was then measured through 
a dissecting microscope fitted with an eyepiece crosshair reticule by using 
a digital micrometer to translate the chamber under the field of view from 
the proximal EDL origin to the distal myotendinous junction. An electrical 
stimulator (FHC, Inc.) provided muscle activation via platinum plate elec-
trodes. Muscle twitches were elicited at successively higher stimulation   JCB • VOLUME 189 • NUMBER 1 • 2010   108
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